Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
12.15
+1.59 (15.06%)
Jul 2, 2025, 10:53 AM - Market open
Eyenovia Revenue
Eyenovia had revenue of $14.72K in the quarter ending March 31, 2025, with 194.81% growth. This brings the company's revenue in the last twelve months to $67.06K, up 663.82% year-over-year. In the year 2024, Eyenovia had annual revenue of $57.34K with 1,414.02% growth.
Revenue (ttm)
$67.06K
Revenue Growth
+663.82%
P/S Ratio
194.40
Revenue / Employee
$4,790
Employees
14
Market Cap
62.02M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
EYEN News
- 13 days ago - Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings - PRNewsWire
- 14 days ago - Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group - GlobeNewsWire
- 14 days ago - Eyenovia Surges on Crypto Announcement - Market Watch
- 14 days ago - Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy - GlobeNewsWire
- 6 weeks ago - Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - GlobeNewsWire
- 3 months ago - Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewsWire
- 4 months ago - Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewsWire